Showing posts with label TAVR Market. Show all posts
Showing posts with label TAVR Market. Show all posts

Friday, 10 August 2018

Global Transcatheter Aortic Valve Replacement (TAVR) Market 2023 | Edward Life Sciences, Medtronic, Boston Scientific, St. Jude Medical, Jena Valve

Researchmoz presents this most up-to-date research on "Global Transcatheter Aortic Valve Replacement (TAVR) Market (Value, Volume): Analysis By Type of Approach (Transfemoral, Transapical), By Region, By Country (2018 Edition): Forecast to 2023". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the market.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Transcatheter Aortic Valve Replacement (TAVR) Market by Type of Approach (Transfemoral and Transapical), By Region (North America, Europe, Asia Pacific, Rest of the world) and By Country (U.S., Canada, Germany, France, United Kingdom, India, Japan China, Brazil and South Africa).

Click to get Sample PDF @ https://www.researchmoz.us/enquiry.php?type=S&repid=1767134

According to Azoth Analytics research report “Global Transcatheter Aortic Valve Replacement (TAVR) Market (Value, Volume): Analysis By Type of Approach (Transfemoral, Transapical), By Region, By Country (2018 Edition): Forecast to 2023 - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, France, United Kingdom, India, Japan China, Brazil, South Africa)” global market is projected to display a robust growth represented by a high CAGR of 14.70 % during 2018 – 2023.

Transcatheter aortic valve replacement has been a ground-breaking advancement in the field of interventional cardiology and cardiovascular surgery. Although, surgical aortic valve replacement is considered the standard treatment, yet 30% of patients are not considered candidates for traditional open heart surgery because of advanced age and presence of multiple comorbidities. TAVR offers this population a less invasive treatment option also with better outcomes. Over the recent years, the global TAVR industry has been growing rapidly mainly due to growing number of elderly population, rising awareness about minimally invasive devices, new device approvals and increasing health expenditure in developing countries. The procedure of transcatheter aortic valve replacement through transfemoral retrograde is the most common catheter-based approach and is performed in approximately 70% to 80% of the total TAVR cases, globally. Hence, this segment holds majority share in the market. This trend is anticipated to continue in the forecast period as well.

Amongst the regions, North America accounts for the largest regional share in the global transcatheter aortic valve replacement market in 2018. However, Asia Pacific is predicted to advance at the highest rate, mainly driven by increase in healthcare expenditure coupled with growing penetration and awareness about technologically advanced heart valve therapies.

The report titled “Global Transcatheter Aortic Valve Replacement (TAVR) Market (Value, Volume): Analysis By Type of Approach (Transfemoral, Transapical), By Region, By Country (2018 Edition): Forecast to 2023 - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, France, United Kingdom, India, Japan China, Brazil, South Africa)” has covered and analyzed the potential of global transcatheter aortic valve replacement market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global transcatheter aortic valve replacement market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-transcatheter-aortic-valve-replacement-tavr-market-value-volume-analysis-by-type-of-approach-transfemoral-transapical-by-region-by-country-2018-report.html/toc

Scope of the Report

Global Transcatheter Aortic Valve Replacement (TAVR) Market
(Actual Period: 2013-2017, Forecast Period: 2018-2023)

- Transcatheter Aortic Valve Replacement (TAVR) Market – Size and Growth:
- By Value, By Volume.
- By Type of Approach – Transfemoral and Transapical: By Value.

Regional Markets

- North America, Europe, APAC and Rest of the World
- (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Transcatheter Aortic Valve Replacement (TAVR) Market – Size and Growth:
- By Value, By Volume.
- By Type of Approach – Transfemoral and Transapical: By Value.

Country Analysis

- U.S., Canada, Germany, France, United Kingdom, India, Japan China, Brazil, South Africa (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Transcatheter Aortic Valve Replacement (TAVR) Market – Size and Growth: By Value, By Volume.
- By Type of Approach – Transfemoral and Transapical: By Value.

Other Report Highlights

- Market Dynamics – Drivers and Restraints
- Market Trends
- Pricing Analysis
- Product Launches and Recent Approvals
- Company Share Analysis
- SWOT Analysis
- Porter Five Force Analysis
- Supply Chain Analysis
- Policy and Regulatory Landscape
- Company Analysis – Edward Life Sciences, Medtronic, Boston Scientific Corporation, St. Jude Medical, Jena Valve, Meril Life Sciences Pvt. Ltd.

Thursday, 28 December 2017

Transcatheter Aortic Valve Replacement (TAVR) Global Market: Industry Analysis & Outlook (2017-2021) | Edwards Lifesciences, Boston Scientific, Medtronic Plc., St. Jude Medical, Inc.

Researchmoz added Most up-to-date research on "Global Transcatheter Aortic Valve Replacement (TAVR) Market: Industry Analysis & Outlook (2017-2021)" to its huge collection of research reports.

Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less intrusive method of replacing heart valve without undergoing the conventional by-pass surgery. Due to the less invasive nature of the surgery, it has emerged as the more feasible alternative to conventional surgical aortic valve replacement. Transcatheter aortic valve replacement is sometimes called as Transcatheter aortic valve implantation (TAVI). TAVR may be an option for people who are considered at intermediate or high risk of complications from surgical aortic valve replacement. It may also be suggested in certain cases where patient cannot undergo open-heart surgery. The decision to treat aortic stenosis with TAVR is made after consultation with a multidisciplinary group of medical and surgical heart specialists who together determine the best treatment option for each individual.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1012263

The global TAVR market is set to experience favourable growth driven by factors such as increasing elderly population, rising health care expenditure, increasing obese population and global economic development. Further, the scope of growth for this market will be broadened by increasing prevalence of aortic stenosis amongst the patients and rising demand for minimally invasive procedures. However, the growth of this budding market will be hindered by the business cycle fluctuations and risk of security breaches such as stringent regulations, high cost of TAVR devices and high risks associated with the TAVR procedure.

The report “Global TAVR Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus on the U.S, Asia Pacific and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and St. Jude Medical, Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVR market along with the study of the regional markets.

Table of Content

1. Introduction
1.1 TAVR Overview

2. Global Market Analysis
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-transcatheter-aortic-valve-replacement-tavr-market-industry-analysis-outlook-20172021-report.html/toc

3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. TAVR Market by Value
3.1.2 The U.S TAVR Forecast by Value
3.1.3 The U.S. TAVR Implant Volume
3.1.4 The U.S. TAVR Implant Volume Forecast
3.1.5 The U.S. TAVR Implant Volume by Patient Type
3.1.6 The U.S. TAVR Implant Volume Forecast-Patient Type
3.1.7 The U.S. TAVR Implant Volume by Access Route
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
3.2 Outside the U.S.
3.2.1 OUS TAVR Market by Value
3.2.2 OUS TAVR Market Forecast by Value
3.2.3 OUS TAVR Implant Volume
3.2.4 OUS TAVR Implant Forecast by Volume
3.2.5 OUS TAVR Patient Population
3.2.6 OUS TAVR Patient Population Forecast
3.2.7 Europe TAVR Implant Volume by Patient Type
3.2.8 Europe TAVR Implant Volume Forecast by Patient Type
3.2.9 Europe TAVR Implant Volume by Access Route

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Aging Population
4.1.2 Rising HealthCare Expenditure
4.1.3 Increasing Obese Population
4.1.4 Economic Development
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Recent Technological Advancements
4.2.2 Favourable Reimbursement Policies in Europe
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 High Cost of TAVR Devices
4.3.3 Associated High Risk

5. Competition
5.1 Global Market
5.1.1 Global TAVR Market Share by Company
5.1.2 Global TAVR Market-Implanting Centres by Company
5.1.3 Global TAVR Market-Total Implants by Company
5.1.4 Global TAVR Market-Average Selling Price of Implants by Company
5.2 The U.S.
5.2.1 The U.S. TAVR Market Share by Company
5.2.2 The U.S. TAVR Market-Implanting Centres by Company
5.2.3 The U.S. TAVR Market-Total Implants by Company
5.2.4 The U.S. TAVR Market-Average Selling Price of Implants by Company
5.3 Outside the U.S.
5.3.1 OUS TAVR Market Share by Company
5.3.2 OUS TAVR Market- Implanting Centres by Company
5.3.3 OUS TAVR Market- Total Implants by Company
5.3.4 OUS TAVR Market-Average Selling Price of Implants by Company

Continue...

Monday, 11 September 2017

Comprehensive Analysis Of The Global Transcatheter Aortic Valve Replacement (TAVR) Market Along With The Study Of The Regional Markets

Researchmoz added Most up-to-date research on "Global Transcatheter Aortic Valve Replacement (TAVR) Market: Industry Analysis & Outlook (2017-2021)" to its huge collection of research reports.

Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less intrusive method of replacing heart valve without undergoing the conventional by-pass surgery. Due to the less invasive nature of the surgery, it has emerged as the more feasible alternative to conventional surgical aortic valve replacement. Transcatheter aortic valve replacement is sometimes called as Transcatheter aortic valve implantation (TAVI). TAVR may be an option for people who are considered at intermediate or high risk of complications from surgical aortic valve replacement. It may also be suggested in certain cases where patient cannot undergo open-heart surgery. The decision to treat aortic stenosis with TAVR is made after consultation with a multidisciplinary group of medical and surgical heart specialists who together determine the best treatment option for each individual.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1012263

The global TAVR market is set to experience favourable growth driven by factors such as increasing elderly population, rising health care expenditure, increasing obese population and global economic development. Further, the scope of growth for this market will be broadened by increasing prevalence of aortic stenosis amongst the patients and rising demand for minimally invasive procedures. However, the growth of this budding market will be hindered by the business cycle fluctuations and risk of security breaches such as stringent regulations, high cost of TAVR devices and high risks associated with the TAVR procedure.

The report “Global TAVR Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus on the U.S, Asia Pacific and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and St. Jude Medical, Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVR market along with the study of the regional markets.

Browse Detail Report With Full TOC @ http://www.researchmoz.us/global-transcatheter-aortic-valve-replacement-tavr-market-industry-analysis-outlook-20172021-report.html

Table of Content

1. Introduction
1.1 TAVR Overview

2. Global Market Analysis
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast

3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. TAVR Market by Value
3.1.2 The U.S TAVR Forecast by Value
3.1.3 The U.S. TAVR Implant Volume
3.1.4 The U.S. TAVR Implant Volume Forecast
3.1.5 The U.S. TAVR Implant Volume by Patient Type
3.1.6 The U.S. TAVR Implant Volume Forecast-Patient Type
3.1.7 The U.S. TAVR Implant Volume by Access Route
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
3.2 Outside the U.S.
3.2.1 OUS TAVR Market by Value
3.2.2 OUS TAVR Market Forecast by Value
3.2.3 OUS TAVR Implant Volume
3.2.4 OUS TAVR Implant Forecast by Volume
3.2.5 OUS TAVR Patient Population
3.2.6 OUS TAVR Patient Population Forecast
3.2.7 Europe TAVR Implant Volume by Patient Type
3.2.8 Europe TAVR Implant Volume Forecast by Patient Type
3.2.9 Europe TAVR Implant Volume by Access Route

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Aging Population
4.1.2 Rising HealthCare Expenditure
4.1.3 Increasing Obese Population
4.1.4 Economic Development
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Recent Technological Advancements
4.2.2 Favourable Reimbursement Policies in Europe
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 High Cost of TAVR Devices
4.3.3 Associated High Risk

5. Competition
5.1 Global Market
5.1.1 Global TAVR Market Share by Company
5.1.2 Global TAVR Market-Implanting Centres by Company
5.1.3 Global TAVR Market-Total Implants by Company
5.1.4 Global TAVR Market-Average Selling Price of Implants by Company
5.2 The U.S.
5.2.1 The U.S. TAVR Market Share by Company
5.2.2 The U.S. TAVR Market-Implanting Centres by Company
5.2.3 The U.S. TAVR Market-Total Implants by Company
5.2.4 The U.S. TAVR Market-Average Selling Price of Implants by Company
5.3 Outside the U.S.
5.3.1 OUS TAVR Market Share by Company
5.3.2 OUS TAVR Market- Implanting Centres by Company
5.3.3 OUS TAVR Market- Total Implants by Company
5.3.4 OUS TAVR Market-Average Selling Price of Implants by Company

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1012263

Monday, 15 May 2017

Global Transcatheter Aortic Valve Replacement (TAVR) Market Key Trends, Size, Growth, Shares And Forecast Outlook to 2019

Researchmoz added Most up-to-date research on "Global Transcatheter Aortic Valve Replacement (TAVR) Market Outlook to 2019" to its huge collection of research reports.

Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less invasive method of replacing heart valve without undergoing the conventional by-pass surgery. Aortic valve replacement typically requires open heart surgery, thus it disqualifies patients who are at high risk for the process or are too weak to undergo a surgery. As a result, the market of heart valve surgical procedures is witnessing a continuous decline as more and more patients requiring valve replacement are at risk for a surgical treatment. This shortcoming of the traditional surgical method has paved way for the popularity and adoption of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market for TAVR is regarded to be promising with immense growth opportunities and unmet demand to cater to.

Rise in economic development, increasing old age population, growing obese population, and increase of aortic stenosis patients are some of the key drivers fueling the development of the global TAVR market. Growth of this market is largely dependent on macro indicators, like global GDP and global healthcare expenditure.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=553671

This report analyzes the development of "global TAVR market", with special focus on the major markets like the United States and Europe. The major market trends and drivers that facilitate the growth of this market as well as the challenges it is facing are also analyzed in this report. The top players operating in the TAVR industry include Edward Lifesciences, Medtronic and St. Jude Medical and these companies have been profiled in the report highlighting their key financials and business strategies for growth and market expansion.

Table of Content

1. Market Overview

2. TAVR Market Analysis
2.1 Global Market

    TAVR Market Value: Actual & Forecast
    Implants Sold: Actual & Forecast

2.2 Regional Markets
2.2.1 US Market

    TAVR Market Value: Actual & Forecast
    Implants Sold: Actual & Forecast   
    Patients at High Risk: Actual & Forecast
    Implants by Patient Type: Actual & Forecast   
    Implants by Access Route: Actual & Forecast

2.2.2 Outside US Market

    TAVR Market Value: Actual & Forecast
    Patients at High Risk: Actual & Forecast
    EU Implants Sold: Actual & Forecast   
    EU Implants by Patient Type: Actual & Forecast   
    EU Implants by Access Route: Actual & Forecast

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Increasing Ageing Population   
3.1.2 Rising Global Healthcare Expense   
3.1.3 Increasing Obese Population   
3.1.4 Global Economic Development   
3.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
3.2 Challenges
3.2.1 Regulatory Issues   
3.2.2 Associated High Risk   
3.2.3 High Cost of TAVR Devices
3.3 Key Trends
3.3.1 Favorable Reimbursement in Europe   
3.3.2 Positive Outcomes from SAPIEN 3   
3.3.3 TAVR for Low Risk Patients   
3.3.4 Edwards Dominates TAVR Market

4. Competitive Landscape
4.1 Global Market

    Product Comparison
    Market Share
    Implant Centers by Company   
    Implant Volume by Company
    ASP Comparison

4.2 US   

    Market Share
    Implant Centers by Company   
    Implant Volume by Company
    ASP Comparison

4.3 Outside US   

    Market Share
    Implant Centers by Company   
    Implant Volume by Company
    ASP Comparison

5. Company Profiles
5.1 Edwards Lifesciences
5.1.1 Business Overview   
5.1.2 Financial Overview   
5.1.3 Business Strategies
5.2 Medtronic
5.2.1 Business Overview   
5.2.2 Financial Overview   
5.2.3 Business Strategies
5.3 St. Jude Medical
5.3.1 Business Overview   
5.3.2 Financial Overview   
5.3.3 Business Strategies

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=553671

Thursday, 20 April 2017

Global Transcatheter Aortic Valve Replacement (TAVR) Industry Key Trends, Size, Growth, Shares And Forecast Research Report (2017-2021)

Researchmoz added Most up-to-date research on "Global Transcatheter Aortic Valve Replacement (TAVR) Market: Industry Analysis & Outlook (2017-2021)" to its huge collection of research reports.

Transcatheter aortic valve replacement (TAVR) is a relatively new technology in the field of medical science. It is a less intrusive method of replacing heart valve without undergoing the conventional by-pass surgery. Due to the less invasive nature of the surgery, it has emerged as the more feasible alternative to conventional surgical aortic valve replacement. Transcatheter aortic valve replacement is sometimes called as Transcatheter aortic valve implantation (TAVI). TAVR may be an option for people who are considered at intermediate or high risk of complications from surgical aortic valve replacement. It may also be suggested in certain cases where patient cannot undergo open-heart surgery. The decision to treat aortic stenosis with TAVR is made after consultation with a multidisciplinary group of medical and surgical heart specialists who together determine the best treatment option for each individual.

The global TAVR market is set to experience favourable growth driven by factors such as increasing elderly population, rising health care expenditure, increasing obese population and global economic development. Further, the scope of growth for this market will be broadened by increasing prevalence of aortic stenosis amongst the patients and rising demand for minimally invasive procedures. However, the growth of this budding market will be hindered by the business cycle fluctuations and risk of security breaches such as stringent regulations, high cost of TAVR devices and high risks associated with the TAVR procedure.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1012263

The report “Global TAVR Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus on the U.S, Asia Pacific and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Edwards Lifesciences, Boston Scientific, Medtronic Plc. and St. Jude Medical, Inc. are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global TAVR market along with the study of the regional markets.

Table of Content

1. Introduction
1.1 TAVR Overview

2. Global Market Analysis
2.1 Global TAVR Market by Value
2.2 Global TAVR Market Forecast by Value
2.3 Global TAVR Implant Volume
2.4 Global TAVR Implant Volume Forecast
2.5 Global TAVR Patient Population
2.6 Global TAVR Patient Population Forecast

3. Regional Market Analysis
3.1 The U.S.
3.1.1 The U.S. TAVR Market by Value
3.1.2 The U.S TAVR Forecast by Value
3.1.3 The U.S. TAVR Implant Volume
3.1.4 The U.S. TAVR Implant Volume Forecast
3.1.5 The U.S. TAVR Implant Volume by Patient Type
3.1.6 The U.S. TAVR Implant Volume Forecast-Patient Type
3.1.7 The U.S. TAVR Implant Volume by Access Route
3.1.8 The U.S. Aortic Valve Disease Patient Population Forecast
3.2 Outside the U.S.
3.2.1 OUS TAVR Market by Value
3.2.2 OUS TAVR Market Forecast by Value
3.2.3 OUS TAVR Implant Volume
3.2.4 OUS TAVR Implant Forecast by Volume
3.2.5 OUS TAVR Patient Population
3.2.6 OUS TAVR Patient Population Forecast
3.2.7 Europe TAVR Implant Volume by Patient Type
3.2.8 Europe TAVR Implant Volume Forecast by Patient Type
3.2.9 Europe TAVR Implant Volume by Access Route

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Aging Population
4.1.2 Rising HealthCare Expenditure
4.1.3 Increasing Obese Population
4.1.4 Economic Development
4.1.5 Increasing Prevalence of Inoperable Aortic Stenosis
4.2 Key Trends & Development
4.2.1 Recent Technological Advancements
4.2.2 Favourable Reimbursement Policies in Europe
4.3 Challenges
4.3.1 Stringent Regulations
4.3.2 High Cost of TAVR Devices
4.3.3 Associated High Risk

5. Competition
5.1 Global Market
5.1.1 Global TAVR Market Share by Company
5.1.2 Global TAVR Market-Implanting Centres by Company
5.1.3 Global TAVR Market-Total Implants by Company
5.1.4 Global TAVR Market-Average Selling Price of Implants by Company
5.2 The U.S.
5.2.1 The U.S. TAVR Market Share by Company
5.2.2 The U.S. TAVR Market-Implanting Centres by Company
5.2.3 The U.S. TAVR Market-Total Implants by Company
5.2.4 The U.S. TAVR Market-Average Selling Price of Implants by Company
5.3 Outside the U.S.
5.3.1 OUS TAVR Market Share by Company
5.3.2 OUS TAVR Market- Implanting Centres by Company
5.3.3 OUS TAVR Market- Total Implants by Company
5.3.4 OUS TAVR Market-Average Selling Price of Implants by Company

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1012263

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...